Chemed Corp. (CHE) stock forecast and price target
Price $548.20 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($548.20)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $25.78 | +19.6% | $2.7B |
| Next fiscal year ends December 31, 2027 | $27.85 | +8.1% | $2.9B |
| Next quarter ends December 31, 2026 | $7.35 | +14.5% | $712M |
| Quarter after ends March 31, 2027 | $6.10 | +8.0% | $713M |
Consensus of the analysts covering Chemed, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 12.6% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Chemed’s intrinsic value about 7% below today’s market value, and it scores 2.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Chemed stock price target?
The average 12-month target from 5 analysts is $617.00, 12.6% above the current price of $548.20 Targets range from $580.00 to $675.00.
Is Chemed a buy according to analysts?
The consensus rating is “Buy” (3 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Chemed expected to earn?
Analysts expect EPS of $25.78 for the fiscal year ending December 31, 2026 and $27.85 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.